Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Orodispersible Film

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2019 - Volume 23, Number 1
View All Articles in Issue

Page(s):  59

Orodispersible Film Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Orodispersible Film. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, oral mucosa, buccal administration, sublingual administration, drug vehicle

Related Categories: EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Orodispersible Film
Allen Loyd V Jr
Jan/Feb 2019
Pg. 59

Orodispersible Films for Compounding Pharmacies
Ferreira Anderson O
, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
Nov/Dec 2017
Pg. 454-461

Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience
Apolinário Régis De Souza
, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa
Nov/Dec 2018
Pg. 512-515

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67

Oral Film Strip Vehicle
Allen Loyd V Jr
Mar/Apr 2011
Pg. 164

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Basics of Compounding: Compounding Films
Allen Loyd V Jr
Jul/Aug 2016
Pg. 298-305

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A
, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 270-280

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
Jul/Aug 2011
Pg. 302-307

Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E
, Aclan Jennifer, Szatkowski Aaron
Sep/Oct 2008
Pg. 463-466

Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A
, Saenz Christopher
Jul/Aug 2002
Pg. 311-315

Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
Jul/Aug 2020
Pg. 296-297

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
Jan/Feb 2023
Pg. 22-23

U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T
, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jan/Feb 2019
Pg. 32-33

Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Kupiec Tom
, Kemp Jesse
Jul/Aug 2007
Pg. 326-327

Return to Top